(Date:11/25/2009)...Scientists at the California Institute of Technolo...e emotion-like behavior in the fruit fly, Drosoph...e relevant to the relationship between the neurotr...vity disorder (ADHD), are described in the Decembe...la brain contains only about 20,000 neurons and h...
(Date:11/25/2009)...teria don,t have easy lives. In addition to mammal...e natural enemies called bacteriophages, viruses t.... , Still, bacteria and another class of microo...me environments such as deep-sea volcanic vents) m...ave a built-in defense system that helps protect t...
(Date:11/25/2009)...sch, Head of the Cell Death Research Laboratory in...has been awarded the prestigious Johnson & Johnson...the cause of brain cell damage in Parkinson,s dise...ntists in support of innovation and excellence in ...ferred earlier this month at an event at the Hyatt...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New Report Emphasizes Critical Role of Including Early and Preventative Care for Women in Health Care Reform 48963 1New Report Emphasizes Critical Role of Including Early and Preventative Care for Women in Health Care Reform 48963 2Insmed CEO Resigns Due to Health Concerns 12633 1Insmed CEO Resigns Due to Health Concerns 12633 2Insmed CEO Resigns Due to Health Concerns 12633 3Colonoscopy Risks Increase With Age and Illness 48960 1Colonoscopy Risks Increase With Age and Illness 48960 2Colonoscopy Risks Increase With Age and Illness 48960 3(Date:11/24/2009)...24 NeurogesX, Inc. (Nasd...n developing and commercializing novel pain manage...no, President and Chief Executive Officer, is sche...Health Care Conference, to be held December 1-2, 2...York. ,, Mr. DiTonno and Stephen Ghiglieri, Ch...
(Date:11/24/2009)...ly approved the Promega PowerPlex 16 HS System for...g DNA records for the National DNA Index System. ...-- The FBI recently approved the Promega PowerPle...cipating in, or generating DNA records for, the Na...tains more than seven million profiles and has ass...
(Date:11/24/2009)...Newswire-FirstCall/ -- Shire plc (LSE: SHP,NASDAQ... company, today,announced that it has submitted a ...rase alfa, the company,s enzyme replacement therap...er disease. This is the third marketing,applicatio...with previous,submissions in the United States and...
(Date:11/24/2009)...r 24 Health Robotics today announc... with a group of selected,investors. This recently...he,name Health Robotics Canada, Inc. and will mark...m of the Future concept, which includes the,revolu...T(TM), and OMM(TM).,Health Robotics Canada Inc. wi...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3...me Therapeutics, Inc.,(Nasdaq: HALO ), a biopharm...roducts targeting the extracellular matrix for the...ology markets, today reported financial,results fo...08., "The fundamentals for Halozyme have never be...f our Phase 2 insulin clinical trial. The,study wi...
...re-FirstCall/ - Dr. Brad Thompson, President,and C...NCY), will present a,corporate overview of the Com...e Conference on Tuesday, November 11, 2008 at 11:1...Palace Hotel from November 10-12, 2008., A live a... at:, http://www.wsw.com/webcast/rrshq14/oncy or ...
...ate Highlights:, * Submitted NDA with FDA for NGX... with PHN, * Responded to EM...er review for NGX-4010 in peripheral neu...sX, Inc.,(Nasdaq: NGSX ), a biopharmaceutical com...el pain management therapies, today reported resul...
Other Biology Technology:Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 2Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 3Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 4Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 5Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 6Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 7Halozyme Therapeutics Reports 2008 Third Quarter Financial Results 8Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference 2NeurogesX Reports Third Quarter 2008 Results 2NeurogesX Reports Third Quarter 2008 Results 3NeurogesX Reports Third Quarter 2008 Results 4NeurogesX Reports Third Quarter 2008 Results 5NeurogesX Reports Third Quarter 2008 Results 6NeurogesX Reports Third Quarter 2008 Results 7NeurogesX Reports Third Quarter 2008 Results 8NeurogesX Reports Third Quarter 2008 Results 9Rabbit Anti-Mouse SHPRH Polyclonal Antibody, Unconjugated from IMGENEX
Rabbit Anti-PI3K p110 delta (Poly6049) Polyclonal Antibody, Unconjugated from BioLegend
Rabbit Anti-Tyrosine Hydroxylase, phospho (Ser40) Polyclonal Antibody, Unconjugated from IMGENEX
NF kappa B Related Sampler Kit from BD Biosciences Pharmingen
Biology Products: